Gelsomino, F.; Fiorentino, M.*; Zompatori, M.; Poerio, A.; Melotti, B.; Sperandi, F.; Gargiulo, M.; Borghi, C.; Ardizzoni, A., Programmed death-1 inhibition and atherosclerosis: Can nivolumab vanish complicated atheromatous plaques?, «ANNALS OF ONCOLOGY», 2018, 29, Article number: mdx718, pp. 284 - 285 [articolo]
Massari F.; Di Nunno V.; Ardizzoni A., Re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62–8, «EUROPEAN UROLOGY», 2018, 73, pp. 72 - 72 [articolo]
Massari F, Di Nunno V, Gatto L, Santoni M, Schiavina R, Cosmai L, Brunocilla E, Ardizzoni A, Porta C, Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy., «TARGETED ONCOLOGY», 2018, 13, pp. 705 - 714 [articolo]
Massari, Francesco; Ciccarese, Chiara; Hes, Ondrej; Michal, Michal; Caliò, Anna; Fiorentino, Michelangelo; Giunchi, Francesca; D'Amuri, Alessandro; Sanguedolce, Francesca; Sabbatini, Roberto; Guida, Annalisa; Ardizzoni, Andrea; Porta, Camillo; Iacovelli, Roberto; Tortora, Giampaolo; Cima, Luca; Ortega, Cinzia; Lapini, Alberto; Martignoni, Guido; Brunelli, Matteo, The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome, «PATHOLOGY ONCOLOGY RESEARCH», 2018, 24, pp. 447 - 456 [articolo]
Massari, Francesco; Ciccarese, Chiara; Hes, Ondrej; Michal, Michal; Caliò, Anna; Fiorentino, Michelangelo; Giunchi, Francesca; D’Amuri, Alessandro; Sanguedolce, Francesca; Sabbatini, Roberto; Guida, Annalisa; Ardizzoni, Andrea; Porta, Camillo; Iacovelli, Roberto; Tortora, Giampaolo; Cima, Luca; Ortega, Cinzia; Lapini, Alberto; Martignoni, Guido; Brunelli, Matteo*, The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome, «PATHOLOGY ONCOLOGY RESEARCH», 2018, 24, pp. 447 - 456 [articolo]
Capizzi, Elisa; Ricci, Costantino; Giunchi, Francesca; Zagnoni, Stefano; Ceccarelli, Claudio; Gómez, Begoña Urrios Álvarez; Casolari, Laura; Gelsomino, Francesco; Trisolini, Rocco; Fiorentino, Michelangelo*; Ardizzoni, Andrea, Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer, «LUNG CANCER», 2018, 126, pp. 9 - 14 [articolo]Open Access
Cho, Byoung Chul*; Kim, Dong-Wan; Bearz, Alessandra; Laurie, Scott A.; McKeage, Mark; Borra, Gloria; Park, Keunchil; Kim, Sang-We; Ghosn, Marwan; Ardizzoni, Andrea; Maiello, Evaristo; Greystoke, Alastair; Yu, Richard; Osborne, Karen; Gu, Wen; Scott, Jeffrey W.; Passos, Vanessa Q.; Lau, Yvonne Y.; Wrona, Anna, ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic NonâSmall Cell Lung Cancer (NSCLC), «JOURNAL OF THORACIC ONCOLOGY», 2017, 12, pp. 1357 - 1367 [articolo]
Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni, Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo, Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer, «UROLOGIC ONCOLOGY», 2017, 35, pp. 541 - 541.e13 [articolo]
Eusebi, Leonardo Henry; Ceccarelli, Claudio; Artesiani, Maria Laura; Montanaro, Lorenzo; Derenzini, Massimo; Dall'Olio, Filippo; Ardizzoni, Andrea; Biasco, Guido; Adua, Daniela; Bazzoli, Franco; Ricciardiello, Luigi, CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS, in: Gastroenterology, 2017, 152, pp. S550 - S550 (atti di: Digestive Disease Week, Chicago, USA, MAY 06-09, 2017) [Contributo in Atti di convegno]
Del Re, Marzia; Tiseo, Marcello; Bordi, Paola; D'Incecco, Armida; Camerini, Andrea; Petrini, Iacopo; Lucchesi, Maurizio; Inno, Alessandro; Spada, Daniele; Vasile, Enrico; Citi, Valentina; Malpeli, Giorgio; Testa, Enrica; Gori, Stefania; Falcone, Alfredo; Amoroso, Domenico; Chella, Antonio; Cappuzzo, Federico; Ardizzoni, Andrea; Scarpa, Aldo; Danesi, Romano, Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA, «ONCOTARGET», 2017, 8, pp. 13611 - 13619 [articolo]
Dika, Emi; Ravaioli, Giulia Maria; Fanti, Pier Alessandro; Piraccini, Bianca Maria; Lambertini, Martina; Chessa, Marco Adriano; Baraldi, Carlotta; Ribero, Simone; Andrea, Ardizzoni; Melotti, Barbara; Patrizi, Annalisa, Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study, «EUROPEAN JOURNAL OF DERMATOLOGY», 2017, 27, pp. 266 - 270 [articolo]
Cavazzoni, Andrea; La Monica, Silvia; Alfieri, Roberta; Ravelli, Andrea; Van Der Steen, Nele; Sciarrillo, Rocco; Madeddu, Denise; Lagrasta, Costanza Anna Maria; Quaini, Federico; Bonelli, Mara; Fumarola, Claudia; Cretella, Daniele; Digiacomo, Graziana; Tiseo, Marcello; Peters, Godefridus J; Ardizzoni, Andrea; Petronini, Pier Giorgio; Giovannetti, Elisa, Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN, «ONCOTARGET», 2017, 8, pp. 53068 - 53083 [articolo]
Fumarola, Claudia*; Cretella, Daniele; La Monica, Silvia; Bonelli, Mara A.; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea, Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism, «ONCOTARGET», 2017, 8, pp. 91841 - 91859 [articolo]
Gadgeel, Shirish*; Goss, Glenwood; Soria, Jean-Charles; Felip, Enriqueta; Georgoulias, Vassilis; Lu, Shun; Cobo, Manuel; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Guclu, Salih Z.; Isla, Dolores; Morabito, Alessandro; Dupuis, Nicholas; Bühnemann, Claudia; Krämer, Nicole; Solca, Flavio; Ehrnrooth, Eva; Ardizzoni, Andrea, Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study, «LUNG CANCER», 2017, 109, pp. 101 - 108 [articolo]
Gelsomino F.; Leonetti A.; Rihawi K.; Sperandi F.; Casolari L.; Melotti B.; Fiorentino M.; Ardizzoni A., Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need?, «TRANSLATIONAL CANCER RESEARCH», 2017, 6, pp. 1484 - 1488 [articolo]
